skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
02/06/2001
Application #:
09481979
Filing Dt:
01/12/2000
Inventors:
Richard Salazar, Walter Rodriguez, James P. Sherbine, Rick G. Woodward et al
Title:
Process For Preparing N6-Substituted Adenosine Derivatives
Assignment: 1
Reel/Frame:
011062/0632Recorded: 10/24/2000Pages: 3
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
12/15/1999
Assignee:
ROUTE 202-206 EMC-G1
BRIDGEWATER, NEW JERSEY 08807
Correspondent:
IRVING NEWMAN,
ROUTE 202-206
PATENTS PHARMACEUTICALS, INC.
PATENT DEPARTMENT, MAILSTOP EMC-G1
BRIDGEWATER NJ 08807-0800
Assignment: 2
Reel/Frame:
011062/0659Recorded: 10/24/2000Pages: 6
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
02/10/2000
Exec Dt:
02/13/2000
Exec Dt:
02/09/2000
Exec Dt:
02/14/2000
Exec Dt:
02/14/2000
Exec Dt:
02/14/2000
Exec Dt:
02/14/2000
Assignee:
500 ARCOLA RD.
COLLEGEVILLE, PENNSYLVANIA 19426
Correspondent:
AVENTIS PHARMACEUTICALS PRODUCTS INC.
IRVING NEWMAN
ROUTE 202-206, MAIL CODE EMC-G1
P.O. BOX 6800
BRIDGEWATER, NJ 08807-0800
Assignment: 3
Reel/Frame:
017636/0360Recorded: 05/18/2006Pages: 5
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
12/31/2001
Assignee:
300 SOMERSET CORPORATE BLVD.
BRIDGEWATER, NEW JERSEY 08807-2854
Correspondent:
ROSS J. OEHLER
ROUTE #202-206/P.O. BOX 6800
MAIL CODE: D303-A
BRIDGEWATER, NJ 08807

Search Results as of: 06/26/2024 05:19 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT